iomeprol has been researched along with Dyslipidemia in 1 studies
iomeprol: structure given in first source
iomeprol : A benzenedicarboxamide compound having N-substituted carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and a glycoloyl(methyl)amino group at the 5-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tajiri, K | 1 |
| Maruyama, H | 1 |
| Sato, A | 1 |
| Shimojo, N | 1 |
| Saito, T | 1 |
| Endo, M | 1 |
| Aihara, H | 1 |
| Kawano, S | 1 |
| Watanabe, S | 1 |
| Sakai, S | 1 |
| Aonuma, K | 1 |
1 other study available for iomeprol and Dyslipidemia
| Article | Year |
|---|---|
Prediction of chronic renal insufficiency after coronary angiography by an early increase in oxidative stress and decrease in glomerular filtration rate.
Topics: Acetylglucosaminidase; Acute Kidney Injury; Aged; Biomarkers; Contrast Media; Coronary Angiography; | 2011 |